Novartis Asset Turnover Over Time
| NVS Stock | USD 95.12 0.76 0.81% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Novartis Performance and Novartis Correlation. Novartis |
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.987 | Dividend Share 3.919 | Earnings Share 4.1 | Revenue Per Share 22.467 | Quarterly Revenue Growth 0.074 |
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Asset Turnover Analysis
Compare Novartis AG ADR and related stocks such as Silver Spike Investment, Alkermes Plc, and Eagle Pharmaceuticals Asset Turnover Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SSIC | 1.0E-4 | 1.0E-4 | 1.0E-4 | 1.0E-4 | 1.0E-4 | 1.0E-4 | 1.0E-4 | 1.0E-4 | 1.0E-4 | 1.0E-4 | 1.0E-4 | 1.0E-4 | 0.0619 | 0.0557 | 0.0585 |
| ALKS | 0.0305 | 0.2717 | 0.3915 | 0.3221 | 0.3221 | 0.3386 | 0.4319 | 0.5026 | 0.5996 | 0.6486 | 0.5328 | 0.5798 | 0.5661 | 0.7787 | 0.82 |
| EGRX | 0.269 | 0.269 | 0.7556 | 0.3576 | 0.5315 | 0.5315 | 0.8872 | 0.8765 | 0.894 | 0.7695 | 0.7417 | 0.6761 | 0.7795 | 0.7 | 0.55 |
| EVO | 0.0856 | 0.3672 | 0.3871 | 0.3779 | 0.3985 | 0.4425 | 0.4682 | 0.3861 | 0.4863 | 0.378 | 0.3424 | 0.2765 | 0.3329 | 0.3 | 0.26 |
Novartis AG ADR and related stocks such as Silver Spike Investment, Alkermes Plc, and Eagle Pharmaceuticals Asset Turnover description
The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.My Equities
My Current Equities and Potential Positions
| Novartis AG ADR | NVS |
 | CompulsionFama & French Classification |
| Location | Switzerland |
| Exchange | New York Stock Exchange |
USD 95.12
Check out Novartis Performance and Novartis Correlation. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Novartis Stock analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Novartis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.